Clinical Trial Update: Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

View source ↗

Summary

This clinical trial update reports the completed study evaluating fludeoxyglucose F-18 positron emission tomography imaging to determine protein and gene expres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Neoplasm of Uncertain Malignant Potential

Drugs mentioned

• Fludeoxyglucose F-18 (FDG) (Fludeoxyglucose F-18)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer, Neoplasm of Uncertain Malignant Potential | Status: COMPLETED